Atlas Trials

Chidamide in Combination With Abemaciclib and Endocrinotherapy(Doctor's Choice) in Breast Cancer Patients Previously Treated With Palbociclib

Clinical trial NCT05464173 · UNKNOWN

Trial details

NCT number
NCT05464173
Sponsor
Biyun Wang, MD
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2022-07-01
Primary completion
2025-02-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.